IBRX vs RGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

IBRX

30.1
AI Score
VS
RGEN Wins

RGEN

41.8
AI Score

Investment Advisor Scores

IBRX

30score
Recommendation
AVOID NEW MONEY

RGEN

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IBRX RGEN Winner
Forward P/E 123.4568 67.1141 RGEN
PEG Ratio 0 1.8399 Tie
Revenue Growth 93.9% 11.9% IBRX
Earnings Growth 0.0% -65.9% IBRX
Tradestie Score 30.1/100 41.8/100 RGEN
Profit Margin 0.0% 5.3% RGEN
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD RGEN

Relative Price Performance (Last 90 Days)

IBRX 1M: +29.4% · 3M: +15.4% RGEN 1M: +5.1% · 3M: +28.4%

Current Technical Phase

IBRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 70

RSI (14): 70.3 · Price: $10.29

RGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.3% over 20 days), RSI 53

RSI (14): 52.9 · Price: $181.70

Fundamentals Snapshot

Metric IBRX RGEN
Market Cap — —
Forward P/E -81.2 68.6
Trailing P/E — 264.5
Revenue (TTM) — —
Revenue Growth 0.9% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin -1.2% 0.1%
EPS -1.02 0.67
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.